Bright Minds Biosciences INC. (DRUG) — 6-K Filings

All 6-K filings from Bright Minds Biosciences INC.. Browse 24 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (24)

Bright Minds Biosciences Files 6-K, Incorporates News Release — Nov 17, 2025 Risk: low
Bright Minds Biosciences Inc. filed a Form 6-K on November 17, 2025, incorporating a news release dated November 17, 2025. This filing is related to their regis
Bright Minds Biosciences Files 6-K Report — Nov 7, 2025 Risk: low
Bright Minds Biosciences Inc. filed a Form 6-K on November 7, 2025, reporting for the month of November 2025. The filing includes a news release dated November
Bright Minds Biosciences: BMB-201 Outperforms Sumatriptan — Sep 5, 2025 Risk: medium
Bright Minds Biosciences Inc. filed a Form 6-K on September 5, 2025, reporting a news release dated September 4, 2025. The news release announced that their dru
Bright Minds Biosciences Files Q3 Financials — Aug 15, 2025 Risk: medium
Bright Minds Biosciences Inc. filed a Form 6-K on August 15, 2025, reporting its Condensed Interim Consolidated Financial Statements for the nine months ended J
Bright Minds Biosciences Files Q2 2025 Financial Update — Aug 11, 2025 Risk: medium
Bright Minds Biosciences Inc. filed a Form 6-K on August 11, 2025, reporting its Condensed Interim Consolidated Financial Statements for the six months ended Ma
Bright Minds Biosciences to Present at Jefferies Healthcare Conference — May 28, 2025 Risk: low
Bright Minds Biosciences Inc. announced on May 28, 2025, that it will present at the 2025 Jefferies Global Healthcare Conference. The company, located at 19 Ves
Bright Minds Biosciences Hosts Absence Epilepsy R&D Day — May 21, 2025 Risk: low
Bright Minds Biosciences Inc. announced on May 20, 2025, that it will host a virtual R&D Day focused on absence epilepsy. The event will feature presentations f
Bright Minds Biosciences Reports Positive Study Findings — May 14, 2025 Risk: medium
Bright Minds Biosciences Inc. filed a Form 6-K on May 14, 2025, reporting on a news release dated May 13, 2025. The news release details positive findings from
Bright Minds Biosciences Files 6-K, Incorporates News Release — Apr 29, 2025 Risk: low
Bright Minds Biosciences Inc. filed a Form 6-K on April 29, 2025, incorporating a news release dated April 28, 2025. This filing is related to their registratio
Bright Minds Biosciences Files 6-K, Incorporates F-3 Registration — Mar 5, 2025 Risk: low
Bright Minds Biosciences Inc. filed a Form 6-K on March 5, 2025, incorporating a news release dated March 4, 2025. This filing is related to their registration
Bright Minds Biosciences to Present at March Healthcare Conferences — Feb 24, 2025 Risk: low
Bright Minds Biosciences Inc. announced on February 24, 2025, that it will participate in three healthcare conferences in March 2025. These conferences include
Bright Minds Biosciences Files Q1 Financial Update — Feb 14, 2025 Risk: medium
Bright Minds Biosciences Inc. filed a Form 6-K on February 14, 2025, reporting its Condensed Interim Consolidated Financial Statements for the three months ende
Bright Minds Biosciences Appoints New Chief Medical Officer — Jan 8, 2025 Risk: low
Bright Minds Biosciences Inc. announced on January 7, 2025, the appointment of Stephen Collins, M.D., Ph.D., as its new Chief Medical Officer. Dr. Collins bring
Bright Minds Biosciences to Present at AES 2024 Meeting — Nov 21, 2024 Risk: low
Bright Minds Biosciences Inc. announced on November 21, 2024, that it will present data at the American Epilepsy Society 2024 Annual Meeting. The company, locat
Bright Minds Biosciences Closes $35M Private Placement — Nov 5, 2024 Risk: medium
Bright Minds Biosciences Inc. announced on November 4, 2024, the closing of a US$35 million non-brokered private placement. The company, headquartered at 19 Ves
Bright Minds Biosciences Partners with Firefly Neuroscience — Oct 21, 2024 Risk: medium
Bright Minds Biosciences Inc. announced on October 21, 2024, a collaboration with Firefly Neuroscience following the BREAKTHROUGH study. The specific details of
Bright Minds Biosciences Files 6-K with Redacted News Release — Oct 18, 2024 Risk: medium
Bright Minds Biosciences Inc. filed a Form 6-K on October 18, 2024, to submit a news release dated October 18, 2024. The news release was embargoed against dist
Bright Minds Biosciences Files 6-K Report — Oct 16, 2024 Risk: low
Bright Minds Biosciences Inc. filed a Form 6-K on October 16, 2024, reporting for the month of October 2024. The filing includes a news release dated October 15
Bright Minds Biosciences Files 6-K Report — Oct 16, 2024 Risk: low
Bright Minds Biosciences Inc. filed a Form 6-K on October 16, 2024, to report information for the month of October 2024. The filing includes a press release dat
Bright Minds Biosciences Files 6-K with Press Release — Oct 3, 2024 Risk: low
Bright Minds Biosciences Inc. filed a Form 6-K on October 3, 2024, to report information as a foreign private issuer. The filing includes a press release dated
Bright Minds Biosciences Files 6-K — Sep 12, 2024 Risk: low
Bright Minds Biosciences Inc. filed a Form 6-K on September 12, 2024, to report a news release dated the same day. The filing does not contain specific financia
Bright Minds Biosciences Files 6-K with Financials — Aug 15, 2024 Risk: medium
Bright Minds Biosciences Inc. filed a Form 6-K on August 15, 2024, reporting its condensed interim consolidated financial statements for the nine months ended J
Bright Minds Biosciences Files 6-K with Meeting Notices — May 17, 2024 Risk: low
Bright Minds Biosciences Inc. filed a Form 6-K on May 17, 2024, reporting information for the month of March 2024. The filing includes a Notice of Meeting and R
Bright Minds Biosciences Files Q4 2023 Interim Financials — Feb 13, 2024 Risk: low
BRIGHT MINDS BIOSCIENCES INC., a foreign private issuer, filed a Form 6-K on February 13, 2024, reporting its Condensed Interim Consolidated Financial Statement

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX